A phase 2a clinical trial to evaluate safety and efficacy of mTORC1 program.
Latest Information Update: 21 Apr 2017
At a glance
- Drugs Dactolisib (Primary) ; Everolimus (Primary)
- Indications Immunodeficiency disorders
- Focus Adverse reactions; Therapeutic Use
- 21 Apr 2017 New trial record